ea0036P18 | (1) | BSPED2014
Kyriakou Andreas
, McNeilly Jane D
, McMillan Martin
, Guftar Shaikh M
, Mason Avril
, Faisal Ahmed S
Introduction: Bisphosphonate therapy (BPT) reduces osteoclast activity and may be associated with adynamic bone turnover. The extent of suppression of bone turnover and its determinants are unclear.Methods: Markers of bone metabolism were evaluated in 15 children (9M/6F) receiving cyclical BPT intravenously for osteoporosis. The median age at first biochemical assessment was 10.8 years (0.16, 16.3). Serum type I collagen cross-linked C-telopeptide (CTX),...